Functional Analysis of Mononuclear Cells Infiltrating into Tumors: Lysis of Autologous Human Tumor Cells by Cultured Infiltrating Lymphocytes
Overview
Authors
Affiliations
Lymphocytes separated from surgically resected tumor tissue, uninvolved lung tissue, and peripheral blood of lung cancer patients were investigated for cytotoxic potential and analyzed for their phenotypes at the time of surgery and after having been propagated for 4 to 5 wk in the presence of interleukin-2. Most of the tumor lymphocyte infiltrates examined were shown to have a shift in favor of T8 subsets from those found in peripheral blood. No natural killer activity and low cytotoxicity against the autologous tumor were found to characterize the tumor-derived lymphocyte population. Propagation of lymphocytes from the different tissues of the cancer patient in the presence of interleukin-2 preparation induced widespread lytic activity against K562 cells, autologous and allogeneic tumors, but not autologous normal lung or lymphoblasts. However, cytotoxic activity against autologous tumor cells exerted by cultured tumor-infiltrating lymphocytes was found to be significantly higher than the activity of cultured lymphocytes isolated from peripheral blood or uninvolved lung tissue of the same patient. The elevated lytic activity of cells derived from the tumor tissue indicates the accumulation at the tumor site of precursors of natural killer-like cells and specifically stimulated antitumor effectors. Our results suggest the coexistence of two types of anti-autotumor cytotoxic lymphocytes at the tumor site: natural killer-like and specific cytotoxic T-cells.
Platelet Lymphocyte Ratio as a Prognosticator in Oral Cancer Patients.
Hamad B, Eltohami Y, Suleiman A J Maxillofac Oral Surg. 2025; 24(1):233-240.
PMID: 39902412 PMC: 11787137. DOI: 10.1007/s12663-023-01959-8.
Factors Associated with Mortality Among Severe Omicron Patients for COVID-19.
Wu S, Liao G, Mao J, Yan H, Chen J, Peng J Infect Drug Resist. 2024; 17:1309-1319.
PMID: 38585415 PMC: 10999197. DOI: 10.2147/IDR.S450504.
Theophilus Yesupatham S, Dayanand C, Azeem Mohiyuddin S, Harendra Kumar M Cells. 2023; 12(10).
PMID: 37408277 PMC: 10217417. DOI: 10.3390/cells12101444.
Pang H, Chen X, Yan M, Chen L, Chen Z, Zhang S Front Oncol. 2023; 13:1021672.
PMID: 37404758 PMC: 10316012. DOI: 10.3389/fonc.2023.1021672.
Huang G, Gao H, Chen Y, Lin W, Shen J, Xu S J Inflamm Res. 2023; 16:1923-1936.
PMID: 37152868 PMC: 10162391. DOI: 10.2147/JIR.S406082.